Andreas Kerschbaumer
About
Andreas Kerschbaumer is a scholar working on Rheumatology, Health, Toxicology and Mutagenesis and Immunology.
According to data from OpenAlex, Andreas Kerschbaumer has authored 74 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Rheumatology, 19 papers in Health, Toxicology and Mutagenesis and 19 papers in Immunology. Recurrent topics in Andreas Kerschbaumer's work include Rheumatoid Arthritis Research and Therapies (28 papers), Air Quality and Health Impacts (18 papers) and Atmospheric chemistry and aerosols (18 papers). Andreas Kerschbaumer is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (28 papers), Air Quality and Health Impacts (18 papers) and Atmospheric chemistry and aerosols (18 papers). Andreas Kerschbaumer collaborates with scholars based in Austria, Germany and United Kingdom. Andreas Kerschbaumer's co-authors include Daniel Aletaha, Josef S Smolen, Désirée van der Heijde, Robert Landewé, Alexandre Sepriano, Maxime Dougados, Josef S Smolen, Louise Falzon, Maarten de Wit and Iain B. McInnes and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and PLoS ONE.
In The Last Decade
Andreas Kerschbaumer
68 papers receiving 1.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Andreas Kerschbaumer Austria | 26 | 851 | 425 | 372 | 351 | 300 | 74 | 1.9k | ||
| Andrew I. Damokosh United States | 22 | 39 0.0× | 158 0.4× | 488 1.3× | 817 2.3× | 240 0.8× | 34 | 2.8k | ||
| Hong Sun United States | 27 | 55 0.1× | 112 0.3× | 562 1.5× | 219 0.6× | 141 0.5× | 44 | 2.6k | ||
| H. Olesen Denmark | 19 | 224 0.3× | 142 0.3× | 40 0.1× | 97 0.3× | 154 0.5× | 75 | 1.0k | ||
| Y Ichikawa Japan | 16 | 167 0.2× | 161 0.4× | 85 0.2× | 94 0.3× | 67 0.2× | 60 | 877 | ||
| Paolo Crosignani Italy | 31 | 68 0.1× | 86 0.2× | 125 0.3× | 734 2.1× | 51 0.2× | 91 | 3.6k | ||
| Yutaka Matsumoto Japan | 29 | 345 0.4× | 89 0.2× | 772 2.1× | 259 0.7× | 1.5k 4.9× | 102 | 3.7k | ||
| Francesca Bruno Italy | 18 | 35 0.0× | 89 0.2× | 218 0.6× | 93 0.3× | 220 0.7× | 76 | 1.2k | ||
| Jiarong Li China | 26 | 127 0.1× | 161 0.4× | 85 0.2× | 122 0.3× | 20 0.1× | 134 | 2.3k | ||
| Yining Huang China | 22 | 33 0.0× | 81 0.2× | 74 0.2× | 315 0.9× | 209 0.7× | 75 | 1.7k | ||
| Lizhi Wu China | 24 | 45 0.1× | 52 0.1× | 496 1.3× | 624 1.8× | 51 0.2× | 81 | 1.8k |
Countries citing papers authored by Andreas Kerschbaumer
Since
Specialization
Citations
This map shows the geographic impact of Andreas Kerschbaumer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Kerschbaumer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Kerschbaumer more than expected).
Fields of papers citing papers by Andreas Kerschbaumer
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Andreas Kerschbaumer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Kerschbaumer. The network helps show where Andreas Kerschbaumer may publish in the future.
Co-authorship network of co-authors of Andreas Kerschbaumer
This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Kerschbaumer. A scholar is included among the top collaborators of Andreas Kerschbaumer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Kerschbaumer. Andreas Kerschbaumer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Engelhardt, Sandy, Guido Schwarzer, Andreas Kerschbaumer, et al.. (2025). Clinical and imaging features of haemochromatosis arthropathy: a systematic literature review and meta-analysis to inform the development of EULAR classification criteria. 1(3). 260–268.
2.
Kerschbaumer, Andreas, et al.. (2025). Global Recruiting Patterns and Placebo Response Rates in Clinical Trials of Psoriatic Arthritis and Plaque Psoriasis. Arthritis & Rheumatology. 78(1). 141–151.
3.
Caseiro, Alexandre, et al.. (2024). Low-cost system application for policy assessment: a case study from Berlin. SHILAP Revista de lepidopterología. 2(3). 35008–35008.
4.
Kerschbaumer, Andreas, Josef S Smolen, Ricardo J O Ferreira, et al.. (2024). Efficacy and safety of pharmacological treatment of psoriatic arthritis: a systematic literature research informing the 2023 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the Rheumatic Diseases. 83(6). 760–774.
5.
Hysa, Elvis, Milena Bond, Lisa Ehlers, et al.. (2023). Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review. Lara D. Veeken. 63(2). 285–297.
6.
Villena, Guillermo, et al.. (2023). Calibrating low-cost sensors to measure vertical and horizontal gradients of NO2 and O3 pollution in three street canyons in Berlin. Atmospheric Environment. 307. 119830–119830.
7.
Kerschbaumer, Andreas, Josef S Smolen, Eirik Klami Kristianslund, et al.. (2023). Definition of rheumatoid arthritis flare based on SDAI and CDAI. Annals of the Rheumatic Diseases. 83(2). 169–176.
8.
Bergstra, Sytske Anne, Alexandre Sepriano, Andreas Kerschbaumer, et al.. (2022). Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 82(1). 81–94.
9.
Kerschbaumer, Andreas, Alexandre Sepriano, Sytske Anne Bergstra, et al.. (2022). Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 82(1). 95–106.
10.
Sepriano, Alexandre, Andreas Kerschbaumer, Sytske Anne Bergstra, et al.. (2022). Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 82(1). 107–118.
11.
Palmowski, Andriko, Frank Buttgereit, Patrick Verschueren, et al.. (2022). Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 81(7). 937–943.
12.
Volta, Marialuisa, U. Giostra, Giorgio Guariso, et al.. (2022). The greatest air quality experiment ever: Policy suggestions from the COVID-19 lockdown in twelve European cities. PLoS ONE. 17(11). e0277428–e0277428.
13.
Caseiro, Alexandre, et al.. (2021). Do new bike lanes impact air pollution exposure for cyclists?—a case study from Berlin. Environmental Research Letters. 16(8). 84031–84031.
14.
Staats, Kevin, Claudia Weidekamm, Andreas Kerschbaumer, et al.. (2020). Hand X-ray examination in two planes is not required for radiographic assessment of hand osteoarthritis. Therapeutic Advances in Musculoskeletal Disease. 12. 1759720X20934934–1759720X20934934.
15.
Sepriano, Alexandre, Andreas Kerschbaumer, Josef S Smolen, et al.. (2020). Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 79(6). 760–770.
16.
Baraliakos, Xenofon, Laure Gossec, Iain McInnes, et al.. (2020). Response to: 'Correspondence on 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update' by Fallon et al. Annals of the Rheumatic Diseases. 81(9). e174–e174.
17.
Kerschbaumer, Andreas, Josef S Smolen, Peter Nash, et al.. (2020). Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research. RMD Open. 6(3). e001374–e001374.
18.
Kerschbaumer, Andreas, Josef S Smolen, Maxime Dougados, et al.. (2020). Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis. Annals of the Rheumatic Diseases. 79(6). 778–786.
19.
Kerschbaumer, Andreas, Alexandre Sepriano, Josef S Smolen, et al.. (2020). Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Annals of the Rheumatic Diseases. 79(6). 744–759.
20.
Kuik, Friderike, Andreas Kerschbaumer, Axel Lauer, et al.. (2018). Top–down quantification of NO x emissions from traffic in an urban area using a high-resolution regional atmospheric chemistry model. Atmospheric chemistry and physics. 18(11). 8203–8225.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Andrew I. Damokosh Breakdown of academic impact, for papers by Hong Sun Breakdown of academic impact, for papers by H. Olesen Breakdown of academic impact, for papers by Y Ichikawa Breakdown of academic impact, for papers by Paolo Crosignani Breakdown of academic impact, for papers by Yutaka Matsumoto Breakdown of academic impact, for papers by Francesca Bruno Breakdown of academic impact, for papers by Jiarong Li Breakdown of academic impact, for papers by Yining Huang Breakdown of academic impact, for papers by Lizhi Wu